# CD248, targeted by veratramine and neobavaisoflavone, mediates pathological changes of renal tubular epithelial cells induced by high glucose

**Authors:** Mei Lin, Nan Hu, Zhen Wang, Ping Li, Dan Song, Xinzhou Zhang

PMC · DOI: 10.1186/s41065-025-00624-z · Hereditas · 2025-12-12

## TL;DR

This study shows that CD248 contributes to kidney damage in diabetes and that two natural compounds, veratramine and neobavaisoflavone, may help treat it.

## Contribution

Identifies CD248 as a key mediator in diabetic nephropathy and introduces two natural compounds that target it.

## Key findings

- CD248 knockdown reduced high glucose-induced cell damage and inflammation in kidney cells.
- Veratramine and neobavaisoflavone inhibited CD248 activity and improved kidney injury in diabetic mice.
- CD248 regulates EMT and fibrosis via the TGF-β1/Smads pathway in diabetic nephropathy.

## Abstract

Epithelial-mesenchymal transition (EMT) of tubular epithelial cells are one of the major pathological changes of diabetic nephropathy (DN). Cluster of differentiation 248 (CD248) has been reported to be associated with fibrosis after kidney injury. The aim of this study was to investigate the mechanism of CD248 in DN and its targeted compounds.

Virtual screening, molecular docking and Cellular thermal shift assays were used to explore potential small molecule compounds targeting CD248. In vitro DN model was established by treating human proximal renal tubular epithelial cell line HK-2 with high glucose (HG), and db/db mice were used as the animal model. siRNA transfection was used to knockdown CD248 in HK-2 cells, and HK-2 cells and the animals were treated with veratramine (VER) or neobavaisoflavone (NBIF). qPCR was used to detect the mRNA expression of CD248, tumor necrosis factor-α (TNF-α), interleukin (IL)-6 (IL-6), and IL-1β. Western blot was used to assess protein expression level of CD248, EMT-associated proteins, fibrosis markers, and TGF-β1/Smads pathway-associated proteins. CCK-8 assay and flow cytometry were used to detect cell viability and apoptosis, respectively. Histopathological and various biochemical indicators were used to assess renal injury in animals.

CD248 was significantly up-regulated in HG-induced HK-2 cells. CD248 knockdown inhibited HG-induced cell proliferation inhibition, apoptosis and inflammatory response. HG stimulation significantly reduced the protein expression level of E-cadherin in HK-2 cells, and increased the expression levels of vimentin, α-smooth muscle actin (α-SMA), collagen I, collagen IV, fibronectin, TGF-β1, p-Smad2, p-Smad3, and Smad4, while CD248 knockdown reversed these effects. In addition, VER and neobavaisoflavone were found to bind with CD248, and they inhibited HG-induced apoptosis, inflammation, EMT and extracellular matrix synthesis in HK-2 cells, and ameliorate the renal injury of db/db mice. VER and NBIF also inhibited HG-induced activation of TGF-β1/Smads axis.

CD248 participates in HG-induced EMT of renal tubular epithelial cells and renal fibrosis by regulating TGF-β1/Smads pathway, and VER and NBIF are two potential natural drugs which targets it to ameliorate DN.

The online version contains supplementary material available at 10.1186/s41065-025-00624-z.

## Linked entities

- **Genes:** CD248 (CD248 molecule) [NCBI Gene 57124], TNF (tumor necrosis factor) [NCBI Gene 7124], IL6 (interleukin 6) [NCBI Gene 3569], IL1B (interleukin 1 beta) [NCBI Gene 3553], shg (shotgun) [NCBI Gene 37386], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446], ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58], vkg (viking) [NCBI Gene 33726], fn1.S (fibronectin 1 S homeolog) [NCBI Gene 397744], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], SMAD4 (SMAD family member 4) [NCBI Gene 4089]
- **Proteins:** CD248 (CD248 molecule), shg (shotgun), PRELID1 (PRELI domain containing 1), vkg (viking), fn1.S (fibronectin 1 S homeolog), TGFB1 (transforming growth factor beta 1), SMAD4 (SMAD family member 4)
- **Chemicals:** veratramine (PubChem CID 6070), neobavaisoflavone (PubChem CID 5320053)
- **Diseases:** diabetic nephropathy (MONDO:0005016)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, Smad3 (SMAD family member 3) [NCBI Gene 17127] {aka Madh3}, Vim (vimentin) [NCBI Gene 22352], Smad2 (SMAD family member 2) [NCBI Gene 17126] {aka 7120426M23Rik, Madh2, Madr2, Smad-2, mMad2}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Smad4 (SMAD family member 4) [NCBI Gene 17128] {aka D18Wsu70e, DPC4, Madh4}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}
- **Diseases:** kidney injury (MESH:D007674), DN (MESH:D003928), inflammation (MESH:D007249), fibrosis (MESH:D005355)
- **Chemicals:** NBIF (MESH:C549830), glucose (MESH:D005947), VER (MESH:C009649), CCK-8 (MESH:D012844)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12781830/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12781830/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12781830/full.md

---
Source: https://tomesphere.com/paper/PMC12781830